PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Revenue 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$336,108FY2025 · since FY2022: $989,042 → $336,108
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $336,108 | -45.5% |
| FY2024 | $617,140 | +10.7% |
| FY2023 | $557,710 | -43.6% |
| FY2022 | $989,042 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PVCT financial trends
PVCT Net incomePVCT Net marginPVCT Gross profitPVCT Gross marginPVCT Operating incomePVCT Operating marginPVCT Operating cash flowPVCT Free cash flowPVCT Capital expendituresPVCT Return on equityPVCT Stock buybacksPVCT Dividends paidPVCT Total assetsPVCT Total liabilitiesPVCT Shareholders’ equityPVCT overview →